A Major Win for Cannabis...

You are receiving this as part of your free subscription to Strategic Tech Investor. To remove your email from this list, unsubscribe here.

Last Chance to Claim Your Spot: New "Radar" Can Hear an Ant's Footsteps An amazing class of devices could replace technologies like GPS, satellite, and radar. It's so powerful that it can actually hear an ant's footsteps... but that's not all. When you see what it does 53 seconds into this presentation, it will blow your mind. But we have to keep this under wraps - and there are fewer than 200 slots open. After tonight, your opportunity will be off the table - and I can't guarantee you will see this ever again. Before this vanishes completely, find out more now. March 31, 2019 Dear Strategic Tech Investor Reader, We're looking at something big, folks: A federal marijuana bill is moving forward in Congress. Of course, it's not full-scale, federal legalization, but it is a step in the right direction. After several days of lengthy debate, the House Financial Services Committee voted 45 to 15 to advance the legislation. I'm talking about the SAFE Act - a bill that will allow banks to provide services like bank accounts for cannabis-related businesses, without the fear of being brought up on federal charges for money laundering, given the banks comply with state laws. Before, cannabis companies weren't allowed to open bank accounts in most banks, due to the federal ban. This meant marijuana businesses were completely cash-based operations - an expensive and, in fact, dangerous way of conducting business A lot of cash was changing hands every day, and everyone knew it. Marijuana-based businesses were at high risk of robbery as a result, and they had to spend extra cash - literally - on expensive surveillance and security. This new bill will completely fix the flawed, and frankly dangerous, system. Not only that, but this bill is opening a big door for cannabis - legitimacy. The days of shady dealers and back-alley transactions are fading, and the black market is slowly being replaced by clean, well-lit stores that... that can now take credit cards. We're looking at the biggest market opportunity since prohibition ended. Now we're seeing new companies cropping up every day, and they're trading for a couple dollars per share - the sort of tiny firms with some of the highest profit potential. Because the industry is so new, it can be hard to separate the next $52 billion company from the firms that won't be worth the paper their stock certificates are printed on. That's where I come in. I'm on the advisory board for the National Institute for Cannabis Investors (NICI), and I've put together an incredibly special deal for you. It'sone that finds and outlines cannabis IPOs, and then delivers the ones with profit potential straight to your inbox. This way, you can get in on major gains, while bypassing all the duds that won't get past the cannabis craze. If you want in on this deal, just click here. Meanwhile, I've been unveiling tons more profit opportunities in my premium services: Nova-X Report and Radical Technology Profits. With two medical pioneers and a totally untapped market on this week's radar, we've got plays you don't want to miss out on. The Untapped CBD Market Set to Explode 400% First, it was the 2018 Farm Bill that gave CBD the greenlight, in the form of CBD-producing hemp plants. Then, it was the World Health Organization, that gave the signal allowing CBD to bypass international regulations, so long as THC levels remained below 0.2%. The CBD markets are gearing up to explode, and you could find yourself with major windfalls... if you know how to play it. How We'll Profit From These Two Medical Pioneers Many investors have never heard of this drug, but it's the first drug on the market that can treat advanced stages of gout, a condition that affects about 50,000 Americans. Right now, drug treatments are few and far between, and sometimes, they don't work at all, so profit margins are high for the company that pulls through with a medicine to treat this "orphan" disease. We've pinpointed the exact company, and it's set to soar... If you Nova-X Report and Radical Technology Profits members haven't caught up on my critical alerts, then take a look. For those of you who aren't yet members, all you need to do is click on the research service or alert that interests you. We're covering everything from marijuana to medtech, and I hope you join us! Of course, there are many more benefits of becoming a member - so I hope you'll check these out. I'll be back next week with more. Cheers and good investing, Michael A. Robinson You are receiving this e-mail at, its028@gmail.com, as a part of your free subscription to Strategic Tech Investor. Remove your email from this list: Unsubscribe Manage Your Email Preferences To cancel by mail or for any other subscription issues, write us at: Strategic Tech Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 Contact Customer Service Website: https://strategictechinvestor.com/ © 2019 Strategic Tech Investor All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Strategic Tech Investor. 1125 N Charles Street, Baltimore MD 21201.